Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Masami Kusaka
Observed names:
Kusaka, M.,
M Kusaka,
M. Kusaka,
Masami KUSAKA
Institution:
Takeda (Japan)
Observed institutions:
National Institutes of Health,
Shimane University,
University of Shimane,
National Cancer Institute,
Takeda (Japan),
Tokushima University
show all 6
OpenAlex ID:
A5075211314
Novel mutations of androgen receptor: a possible mechanism of bicalutamide withdrawal syndrome.
2003
·
Takahito Hara
, Jun-ichi Miyazaki
, et al.
·
PubMed
·
492
Potent anti-angiogenic action of AGM-1470: comparison to the fumagillin parent
1991
·
Masami Kusaka
, Katsuichi Sudo
, et al.
·
Biochemical and Biophysical Research Communications
·
331
Cytostatic inhibition of endothelial cell growth by the angiogenesis inhibitor TNP-470 (AGM-1470)
1994
·
M Kusaka
, K Sudo
, et al.
·
British Journal of Cancer
·
251
PDF
Stimulation of prostaglandin E2 synthesis in cloned osteoblastic cells of mouse (MC3T3-E1) by epidermal growth factor.
1986
·
K Yokota
, M Kusaka
, et al.
·
Journal of Biological Chemistry
·
173
Discovery of orteronel (TAK-700), a naphthylmethylimidazole derivative, as a highly selective 17,20-lyase inhibitor with potential utility in the treatment of prostate cancer
2011
·
Tomohiro Kaku
, Takenori Hitaka
, et al.
·
Bioorganic & Medicinal Chemistry
·
131
Orteronel (TAK-700), a novel non-steroidal 17,20-lyase inhibitor: Effects on steroid synthesis in human and monkey adrenal cells and serum steroid levels in cynomolgus monkeys
2012
·
Masuo Yamaoka
, Takahito Hara
, et al.
·
The Journal of Steroid Biochemistry and Molecular Biology
·
123
Discovery of 1-{4-[1-(2,6-Difluorobenzyl)-5-[(dimethylamino)methyl]-3-(6-methoxypyridazin-3-yl)-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3- d ]pyrimidin-6-yl]phenyl}-3-methoxyurea (TAK-385) as a Potent, Orally Active, Non-Peptide Antagonist of the Human Gonadotropin-Releasing Hormone Receptor
2011
·
Kazuhiro Miwa
, Takenori Hitaka
, et al.
·
Journal of Medicinal Chemistry
·
119
AGM-1470, a potent angiogenesis inhibitor, prevents the entry of normal but not transformed endothelial cells into the G1 phase of the cell cycle.
1994
·
N Antoine
, R Greimers
, et al.
·
PubMed
·
104
Overcoming Persistent Dependency on Androgen Signaling after Progression to Castration-Resistant Prostate Cancer
2010
·
Masuo Yamaoka
, Takahito Hara
, et al.
·
Clinical Cancer Research
·
92
Suppression of the hypothalamic–pituitary–gonadal axis by TAK-385 (relugolix), a novel, investigational, orally active, small molecule gonadotropin-releasing hormone (GnRH) antagonist: Studies in human GnRH receptor knock-in mice
2013
·
Daisuke Nakata
, Tsuneo Masaki
, et al.
·
European Journal of Pharmacology
·
76
Chronic Administration of the Metastin/Kisspeptin Analog KISS1-305 or the Investigational Agent TAK-448 Suppresses Hypothalamic Pituitary Gonadal Function and Depletes Plasma Testosterone in Adult Male Rats
2012
·
Hisanori Matsui
, Akira Tanaka
, et al.
·
Endocrinology
·
69
C17,20-lyase inhibitors. Part 2: Design, synthesis and structure–activity relationships of (2-naphthylmethyl)-1H-imidazoles as novel C17,20-lyase inhibitors
2004
·
Nobuyuki Matsunaga
, Tomohiro Kaku
, et al.
·
Bioorganic & Medicinal Chemistry
·
63
Homeobox genes: Potential candidates for the transcriptional control of the transformed and invasive phenotype
1994
·
Vincent Castronovo
, Masami Kusaka
, et al.
·
Biochemical Pharmacology
·
58
Enhanced androgen receptor signaling correlates with the androgen-refractory growth in a newly established MDA PCa 2b-hr human prostate cancer cell subline.
2003
·
Takahito Hara
, Kazuyo Nakamura
, et al.
·
PubMed
·
57
Effect of interleukin 1 beta on osteoblastic clone MC3T3-E1 cells
1988
·
Eiko Ikeda
, Masami Kusaka
, et al.
·
Calcified Tissue International
·
56
Possible induction of fatty acid cyclooxygenase in mouse osteoblastic cells (MC3T3-E1) by cAMP
1988
·
Masami Kusaka
, Takeo Oshima
, et al.
·
Biochimica et Biophysica Acta (BBA) - Bioenergetics
·
55
C17,20-Lyase inhibitors I. Structure-based de novo design and SAR study of C17,20-lyase inhibitors
2004
·
Nobuyuki Matsunaga
, Tomohiro Kaku
, et al.
·
Bioorganic & Medicinal Chemistry
·
46
Pharmacologic profiles of investigational kisspeptin/metastin analogues, TAK-448 and TAK-683, in adult male rats in comparison to the GnRH analogue leuprolide
2014
·
Hisanori Matsui
, Tsuneo Masaki
, et al.
·
European Journal of Pharmacology
·
38
2-Acylamino-4,6-diphenylpyridine derivatives as novel GPR54 antagonists with good brain exposure and in vivo efficacy for plasma LH level in male rats
2010
·
Toshitake Kobayashi
, Satoshi Sasaki
, et al.
·
Bioorganic & Medicinal Chemistry
·
37
Possible role of adaptive mutation in resistance to antiandrogen in prostate cancer cells
2005
·
Takahito Hara
, Jin Kouno
, et al.
·
The Prostate
·
37
12- and 15-lipoxygenases in rat pineal gland
1984
·
Tanihiro Yoshimoto
, Masami Kusaka
, et al.
·
Prostaglandins
·
37
Effect of a novel 17,20-lyase inhibitor, orteronel (TAK-700), on androgen synthesis in male rats
2012
·
Takahito Hara
, Jin Kouno
, et al.
·
The Journal of Steroid Biochemistry and Molecular Biology
·
34
Design and Synthesis of an Investigational Nonapeptide KISS1 Receptor (KISS1R) Agonist, Ac- d -Tyr-Hydroxyproline (Hyp)-Asn-Thr-Phe-azaGly-Leu-Arg(Me)-Trp-NH2(TAK-448), with Highly Potent Testosterone-Suppressive Activity and Excellent Water Solubility
2016
·
Naoki Nishizawa
, Yoshihiro Takatsu
, et al.
·
Journal of Medicinal Chemistry
·
33
Suppression of a Pituitary-Ovarian Axis by Chronic Oral Administration of a Novel Nonpeptide Gonadotropin-Releasing Hormone Antagonist, TAK-013, in Cynomolgus Monkeys
2003
·
Takahito Hara
, Hideo Araki
, et al.
·
The Journal of Clinical Endocrinology & Metabolism
·
32
Novel benzimidazole derivatives selectively inhibit endothelial cell growth and suppress angiogenesis in vitro and in vivo
2002
·
Akira Hori
, Yasuhiro Imaeda
, et al.
·
Cancer Letters
·
29
Show more works
View as search
Works count:
54
Citation count:
2,847
H-index:
26
I10-index:
39
Year
Topic
Type